248 related articles for article (PubMed ID: 18512025)
21. The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.
Tsirakis G; Pappa CA; Kaparou M; Boula A; Katsomitrou V; Xekalou A; Kyriakaki S; Alexandrakis MG
Tumour Biol; 2013 Apr; 34(2):859-64. PubMed ID: 23242610
[TBL] [Abstract][Full Text] [Related]
22. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.
D'Souza S; del Prete D; Jin S; Sun Q; Huston AJ; Kostov FE; Sammut B; Hong CS; Anderson JL; Patrene KD; Yu S; Velu CS; Xiao G; Grimes HL; Roodman GD; Galson DL
Blood; 2011 Dec; 118(26):6871-80. PubMed ID: 22042697
[TBL] [Abstract][Full Text] [Related]
23. [Regulation of miRNA-15a/-16 expression on the drug resistance of myeloma cells].
Zang MR; Li F; An G; Xie ZQ; Li CH; Yu Z; Xu Y; Qiu LG; Hao M
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1100-3. PubMed ID: 22781767
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor.
Matsuda-Hashii Y; Takai K; Ohta H; Fujisaki H; Tokimasa S; Osugi Y; Ozono K; Matsumoto K; Nakamura T; Hara J
Exp Hematol; 2004 Oct; 32(10):955-61. PubMed ID: 15504551
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients.
Zdzisińska B; Walter-Croneck A; Kandefer-Szerszeń M
Leuk Res; 2008 Nov; 32(11):1763-9. PubMed ID: 18472160
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression.
Liu Z; Xu J; Li H; Zheng Y; He J; Liu H; Zhong Y; Lu Y; Hong B; Zhang M; Lin P; Du J; Hou J; Qian J; Kwak LW; Yi Q; Yang J
PLoS One; 2013; 8(12):e82453. PubMed ID: 24340030
[TBL] [Abstract][Full Text] [Related]
27. The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells.
Tsubaki M; Seki S; Takeda T; Chihara A; Arai Y; Morii Y; Imano M; Satou T; Shimomura K; Nishida S
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114380
[TBL] [Abstract][Full Text] [Related]
28. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion.
Uchiyama H; Barut BA; Mohrbacher AF; Chauhan D; Anderson KC
Blood; 1993 Dec; 82(12):3712-20. PubMed ID: 8260708
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of APE1/Ref-1 and its regulation on IL-6 and IL-8 in bone marrow stromal cells of multiple myeloma.
Xie JY; Li MX; Xiang DB; Mou JH; Qing Y; Zeng LL; Yang ZZ; Guan W; Wang D
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):385-93. PubMed ID: 21030352
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism.
Brown JM; Nemeth K; Kushnir-Sukhov NM; Metcalfe DD; Mezey E
Clin Exp Allergy; 2011 Apr; 41(4):526-34. PubMed ID: 21255158
[TBL] [Abstract][Full Text] [Related]
31. The increased expression of receptor activator of nuclear-kappaB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate.
Fernández M; Pino AM; Figueroa P; Rodríguez JP
J Cell Biochem; 2010 Sep; 111(1):130-7. PubMed ID: 20506157
[TBL] [Abstract][Full Text] [Related]
32. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
Kristensen IB; Pedersen L; Rø TB; Christensen JH; Lyng MB; Rasmussen LM; Ditzel HJ; Børset M; Abildgaard N
Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294
[TBL] [Abstract][Full Text] [Related]
33. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma.
Vincent T; Molina L; Espert L; Mechti N
Br J Haematol; 2003 Apr; 121(2):259-69. PubMed ID: 12694247
[TBL] [Abstract][Full Text] [Related]
35. CD40 ligand triggered interleukin-6 secretion in multiple myeloma.
Urashima M; Chauhan D; Uchiyama H; Freeman GJ; Anderson KC
Blood; 1995 Apr; 85(7):1903-12. PubMed ID: 7535594
[TBL] [Abstract][Full Text] [Related]
36. A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target.
Ferrucci A; Moschetta M; Frassanito MA; Berardi S; Catacchio I; Ria R; Racanelli V; Caivano A; Solimando AG; Vergara D; Maffia M; Latorre D; Rizzello A; Zito A; Ditonno P; Maiorano E; Ribatti D; Vacca A
Clin Cancer Res; 2014 Nov; 20(22):5796-807. PubMed ID: 25212607
[TBL] [Abstract][Full Text] [Related]
37. High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity.
Seidel C; Børset M; Hjertner O; Cao D; Abildgaard N; Hjorth-Hansen H; Sanderson RD; Waage A; Sundan A
Blood; 2000 Nov; 96(9):3139-46. PubMed ID: 11049995
[TBL] [Abstract][Full Text] [Related]
38. Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells.
Gao L; Zhang C; Zhang X; Gao L; Hao L; Chen XH
Hematology; 2014 Apr; 19(3):148-57. PubMed ID: 23896383
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
[TBL] [Abstract][Full Text] [Related]
40. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
